Biotechnology industries
Swiss-based pharmaceutical giant Novartis AG is partnering with US biotech company Human Genome Sciences Inc. to develop and sell Albuferon, a hepatitis C medication. The agreement, announced yesterday, will see Novartis handle sales outside the US, while Human Genome will focus on the US market. Novartis will share the costs
Biotechnology industries
Xechem International Inc.'s (OTCBB: XKEM) announcement that it has received Orphan Drug designation from the FDA for its compound 5-HMF to treat sickle cell disease positions the company uniquely in the pipeline for treating this condition. The SUBWAY.com has added Xechem International, Human Genome Sciences, Inc., Rambus
Drugs
Clinical trials evaluating the systemic administration of OGX-011, an antisense drug, in combination with standard chemotherapy agents, have yielded promising results in patients with non-small cell lung cancer (NSCLC). The phase I study, conducted by OncoGenex Technologies Inc. in collaboration with Isis Pharmaceuticals Inc., demonstrated a 1-year survival rate of
Drugs
Human Genome Sciences, Inc., (HGSI) has announced promising 12-week interim results from a phase IIb clinical trial evaluating the efficacy and safety of Albuferon (albumin-interferon alpha 2b) in combination with ribavirin in patients with genotype 1 chronic hepatitis C (HCV) who are naive to interferon alpha-based treatment regimens. The results
Pharmaceutical industry
PharmaVentures, a leading results-driven organization assisting pharmaceutical and biotechnology companies, has launched a brand new internet-based television show: PharmaVentures Business Review. This monthly series provides viewers with insightful analysis and debate covering major transactions and industry trends, offering exclusive access to topical interviews with senior executives and experts. The show
Pharmaceutical industry
Shares of various retail and medical stocks experienced significant movement on Wednesday following a series of corporate announcements and product recalls. Among them, BJ's Wholesale Club, PetMed Express, Select Comfort, Office Depot, Bausch & Lomb, and AstraZeneca saw notable fluctuations. Billionaire Carl Icahn's 3.7% stake
Biotechnology industries
The biotechnology industry in Australia is crying out for tax breaks to encourage investors to back late-stage drug trials, with the industry's cash-strapped sector facing significant challenges in funding its operations. Leon Serry, an industry stalwart, has been lobbying the Federal Government for a 100% tax deduction for
Biotechnology industries
Oncolytics Biotech Inc., a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, will present a corporate overview at the Rodman & Renshaw 3rd Annual Global Healthcare Conference on May 16, 2006. Dr. Brad Thompson, President and CEO, will lead the presentation at 11:55
Pharmaceutical industry
Cancer patients have received a welcome boost of hope as Cancer Research UK has announced plans to revive a pool of underdeveloped anti-cancer agents left to languish in research laboratories. The charity is partnering with major pharmaceutical and biotechnology companies through its Clinical Development Partnerships (CDP) program, which aims to
Pharmaceutical industry
Researchers at Genentech, Inc. presented preclinical data at the 97th Annual Meeting of the American Association for Cancer Research (AACR) suggesting that a Hedgehog antagonist inhibited the growth of tumors in pancreatic cancer and small cell lung cancer. The data were generated as part of Curis' ongoing collaboration with
Pharmaceutical industry
Epigenomics AG, a molecular diagnostics company, has extended its collaboration with Roche Diagnostics on blood screening products for various cancers for 18 months until September 30, 2007. The initial collaboration, which began in December 2005, focused on a colorectal cancer screening test, and Roche Diagnostics has now decided to extend
Pharmaceutical industry
Zacks Equity Research, a renowned provider of quantitative and qualitative analysis, has selected Linear Technology (LLTC) as the Bull of the Day and Merck & Co., Inc. (MRK) as the Bear of the Day. The company also provides analysis on eBay (EBAY) and Genzyme Corporation (GENZ), highlighting their potential for
